EpiBone
EpiBone is a biomedical engineering company that is developing technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.[1][2]
History
[edit]EpiBone was founded in 2013 by Nina Tandon and Sarindr “Ik” Bhumiratana in New York City.[3] The company’s technology derives from research in bone and osteochondral tissue engineering at Columbia University.[4][failed verification]
See also
[edit]References
[edit]- ↑ "This Woman's Revolutionary Startup Could Change 900,000 Surgeries A Year". Business Insider. Retrieved 2015-10-20.
- ↑ "EpiBone". Retrieved 2022-04-07.
- ↑ "This Startup Wants People to Grow Their Own Bone Transplants". Bloomberg.com. Archived from the original on 2022-12-03. Retrieved 2025-09-07.
- ↑ Murphy, Sean V.; Atala, Anthony (2016). Regenerative Medicine Technology: On-a-Chip Applications for Disease Modeling, Drug Discovery and Personalized Medicine. CRC Press. p. 407. ISBN 9781498711920.
 | This article about biomedical engineering is a stub. You can help Wikipedia by adding missing information. |
 | This article about a corporation or company specializing in health technology is a stub. You can help Wikipedia by adding missing information. |